These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 12822023)

  • 1. [Statins and diabetes--indications and refusal rules].
    Claudi T; Birkeland K; Jensen T
    Tidsskr Nor Laegeforen; 2003 May; 123(11):1564-5. PubMed ID: 12822023
    [No Abstract]   [Full Text] [Related]  

  • 2. [Good prevention of type 2 diabetes with lipid-lowering statin therapy. Intervention studies support active treatment of risk patients].
    Nilsson PM; Attvall S; Båvenholm P
    Lakartidningen; 2004 Nov; 101(47):3798, 3801-2, 3804. PubMed ID: 15609534
    [No Abstract]   [Full Text] [Related]  

  • 3. Sugar and fat, a recipe for disaster. New guidelines for the pharmacological management of diabetic dyslipidaemia.
    Tallis GA; Beng C; Popplewell P; Phillips P
    Aust Fam Physician; 1995 Sep; 24(9):1638-9, 1642-7, 1649. PubMed ID: 7487649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study suggests statins for diabetics with healthy LDL cholesterol levels.
    Rollins G
    Rep Med Guidel Outcomes Res; 2004 Sep; 15(18):1-2, 6-7. PubMed ID: 15452942
    [No Abstract]   [Full Text] [Related]  

  • 5. [CARDS confirms usefulness of LDL lowering in type 2 diabetics].
    Bern VH
    Praxis (Bern 1994); 2004 Oct; 93(44):1 p following 1830. PubMed ID: 15559908
    [No Abstract]   [Full Text] [Related]  

  • 6. [The TNT debate gives a lift to the debate about high-dose statins. Lower LDL cholesterol levels further reduce the cardiovascular risk].
    Olsson AG
    Lakartidningen; 2005 May 2-15; 102(18-19):1393-4. PubMed ID: 15929421
    [No Abstract]   [Full Text] [Related]  

  • 7. [Dyslipidemia, diabetes and cardiovascular disease].
    Hansen CN; Jensen TJ; Borch-Johnsen K
    Ugeskr Laeger; 2000 Aug; 162(33):4367-70. PubMed ID: 10962957
    [No Abstract]   [Full Text] [Related]  

  • 8. [Type 2 diabetics are high risk patients. Concerning LDL-cholesterol to approach effectively to two sources].
    MMW Fortschr Med; 2005 Nov; 147(44):52-3. PubMed ID: 16302495
    [No Abstract]   [Full Text] [Related]  

  • 9. Multitherapy for diabetes.
    Harris SB
    CMAJ; 2006 Nov; 175(10):1247-8. PubMed ID: 17098959
    [No Abstract]   [Full Text] [Related]  

  • 10. [Low carbohydrate diets reduce the need of statin treatment].
    Ravnskov U
    Lakartidningen; 2006 Oct 4-10; 103(40):3017; author reply 3017-8. PubMed ID: 17115674
    [No Abstract]   [Full Text] [Related]  

  • 11. Not all diabetics are created equal (in cardiovascular risk).
    Budoff MJ
    Eur Heart J; 2008 Sep; 29(18):2193-4. PubMed ID: 18687661
    [No Abstract]   [Full Text] [Related]  

  • 12. [Statins and the industry].
    Kjellevand TO
    Tidsskr Nor Laegeforen; 2009 Nov; 129(21):2264. PubMed ID: 19898587
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical significance of recent lipid trials on reducing risk in patients with type 2 diabetes mellitus.
    Jones PH
    Am J Cardiol; 2007 Feb; 99(4A):133B-140B. PubMed ID: 17307065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early screening for diabetes mellitus: has it been overstated?
    Boucher FG
    Can Fam Physician; 2004 Nov; 50():1503-4. PubMed ID: 15597968
    [No Abstract]   [Full Text] [Related]  

  • 15. [Favorable effects of decreasing lipids in patients with diabetes mellitus].
    Gouni-Berthold I; Krone W
    Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S252-4. PubMed ID: 17139581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rediscovering bile acid sequestrants.
    Bell DS; O'Keefe JH
    Diabetes Obes Metab; 2009 Dec; 11(12):1114-21. PubMed ID: 19788434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes as a 'cardiovascular disease equivalent': implications for treatment.
    Laakso M
    Nat Clin Pract Cardiovasc Med; 2008 Nov; 5(11):682-3. PubMed ID: 18797431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention of cardiovascular disease in type 2 diabetic patients].
    Yokota C
    Nihon Rinsho; 2003 Jul; 61(7):1161-6. PubMed ID: 12877078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of combination lipid therapy in the management of patients with type 2 diabetes mellitus in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.
    Tonkin AM; Chen L
    Circulation; 2010 Aug; 122(8):850-2. PubMed ID: 20733114
    [No Abstract]   [Full Text] [Related]  

  • 20. Fenofibrate for cardiovascular disease prevention in metabolic syndrome and type 2 diabetes mellitus.
    Steiner G
    Am J Cardiol; 2008 Dec; 102(12A):28L-33L. PubMed ID: 19084087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.